Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes.
Kefala M, Papageorgiou SG, Kontos CK, Economopoulou P, Tsanas A, Pappa V, Panayiotides IG, Gorgoulis VG, Patsouris E, Foukas PG. Kefala M, et al. Among authors: kontos ck. Leuk Res. 2013 Nov;37(11):1576-82. doi: 10.1016/j.leukres.2013.08.018. Epub 2013 Sep 5. Leuk Res. 2013. PMID: 24054861
Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma.
Psyrri A, Papageorgiou S, Liakata E, Scorilas A, Rontogianni D, Kontos CK, Argyriou P, Pectasides D, Harhalakis N, Pappa V, Kolialexi A, Economopoulou C, Kontsioti F, Maratou E, Dimitriadis G, Economopoulou P, Economopoulos T. Psyrri A, et al. Among authors: kontos ck. Clin Cancer Res. 2009 Sep 15;15(18):5724-32. doi: 10.1158/1078-0432.CCR-08-3215. Epub 2009 Sep 1. Clin Cancer Res. 2009. PMID: 19723646
The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
Papageorgiou SG, Kontos CK, Pappa V, Thomadaki H, Kontsioti F, Dervenoulas J, Papageorgiou E, Economopoulos T, Scorilas A. Papageorgiou SG, et al. Among authors: kontos ck. Oncologist. 2011;16(9):1280-91. doi: 10.1634/theoncologist.2010-0349. Epub 2011 Jul 7. Oncologist. 2011. PMID: 21737576 Free PMC article.
Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
Vasilatou D, Papageorgiou SG, Kontsioti F, Kontos CK, Tsiotra P, Mpakou V, Pavlou MA, Economopoulou C, Dimitriadis G, Dervenoulas J, Pappa V. Vasilatou D, et al. Among authors: kontos ck. Leuk Res. 2013 Mar;37(3):251-8. doi: 10.1016/j.leukres.2012.11.011. Epub 2012 Dec 14. Leuk Res. 2013. PMID: 23246221
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine.
Miltiades P, Lamprianidou E, Vassilakopoulos TP, Papageorgiou SG, Galanopoulos AG, Kontos CK, Adamopoulos PG, Nakou E, Vakalopoulou S, Garypidou V, Papaioannou M, Hatjiharissi E, Papadaki HA, Spanoudakis E, Pappa V, Scorilas A, Tsatalas C, Kotsianidis I; Hellenic MDS Study Group. Miltiades P, et al. Among authors: kontos ck. Clin Cancer Res. 2016 Apr 15;22(8):1958-68. doi: 10.1158/1078-0432.CCR-15-1288. Epub 2015 Dec 23. Clin Cancer Res. 2016. PMID: 26700206
BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.
Papageorgiou SG, Kontos CK, Foukas PG, Panopoulou E, Vasilatou D, Rapti SM, Gkontopoulos K, Bazani E, Panayiotides IG, Dimitriadis G, Scorilas A, Pappa V. Papageorgiou SG, et al. Among authors: kontos ck. Leuk Lymphoma. 2016 Sep;57(9):2199-203. doi: 10.3109/10428194.2015.1126588. Epub 2016 Jan 14. Leuk Lymphoma. 2016. PMID: 27442703 No abstract available.
117 results